17 results
8-K
EX-10.1
ANEB
Anebulo Pharmaceuticals Inc
6 Oct 23
Departure of Directors or Certain Officers
4:10pm
or indirectly, either for himself or on behalf of any other entity, (i) recruit or otherwise solicit or induce any employee, customer, subscriber … , specifications, customer information, customer lists, manufacturing information, marketing information, advertising information, and sales information.
(iii) Work
8-K
EX-10.1
lvm dqviqs
24 May 22
Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
4:05pm
8-K
EX-10.1
ae6wm2
5 Jan 22
Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen
10:00am
S-1
EX-10.2
k65zzdk9efyd9d
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.4
y3eo82
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.1
38f5n22p5
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.5
05u n49k55lfe0e
1 Apr 21
IPO registration
5:19pm
S-1
EX-14.1
5wf2mzir
1 Apr 21
IPO registration
5:19pm
DRS/A
EX-10.1
41j 6um8b04ud
12 Mar 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.4
7wyt9kfvr
12 Mar 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.2
9o76 r86dbhph
12 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next